Novel cancer treatment wins endorsement of FDA advisers – Washington Post
Washington Post |
Novel cancer treatment wins endorsement of FDA advisers
Washington Post Novartis, the drugmaker behind the CAR T-cell therapy, is seeking approval to use it for children and young adults whose leukemia doesn't respond to traditional treatments — a group that numbers 600 or so patients a year in this country. But the … A New Dawn: First CAR T Cell Recommended for FDA Approval FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers Novartis' stellar CAR–T efficacy data steamrolls safety doubts to power landmark cancer therapy toward approval |
